Innovalve

Siddharth Nandyala is the creator of CircadiaV, an innovative AI-powered application that can detect heart diseases within seven seconds using smartphone-based heart sound recordings.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO says can "understand the concept of time and how you change, from cradle to grave.

Beyond speed, AI has also helped reduce costs. Conventional methods required nearly $35,000 per genome analysis, but AI-driven models running on GPUs have lowered the cost to under $2,000, making high-quality genomic research more accessible.

In this digital era, machine learning transforms cardiovascular disease (CVD) management by enhancing prediction accuracy, adapting to evolving medical data, and optimizing treatment. Vikas Nelamangala's research explores innovations in temporal data simulation and drift-resilient models,

Ryan Honary, founder of SensoRy AI, has been working on the project since fifth grade after seeing the devastation of the 2018 Camp fire, which killed 85 people.

A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings clinical laboratory-grade cardiac troponin I (cTnI) testing to a portable, cost-effective point-of-care platform.

We recently published a list of 10 AI News and Ratings Too Important to Miss. In this article, we are going to take a look at where GE HealthCare Technologies Inc. (NASDAQ:GEHC) stands against other AI news and ratings too important to miss.

During a fireside chat at the annual J.P. Morgan Healthcare Conference on January 13th, Mayo Clinic chief administrative officer Christina Zorn shared how the company addresses potential future healthcare worker shortages and improves cancer care by leveraging AI in robotics and pathology database management.